ResearcherCapital Medical UniversityNo recent work listed

Zhiqiang Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1226-5597; OpenAlex author ID A5012686016. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2012: 2 papers

Papers 2

Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. Co-author DOI 10.7314/apjcp.2012.13.3.753 ↗
Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. Co-author DOI 10.7314/apjcp.2012.13.8.3781 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Hui-Sheng Yuan · 2 shared papers, 2012 · strength 0.07
- Paper Knockdown of Ezrin by RNA interference reverses malignant behavior of human pancreatic cancer cells in vitro. DOI 10.7314/apjcp.2012.13.8.3781 ↗
- Paper Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. DOI 10.7314/apjcp.2012.13.3.753 ↗
Na Li · 1 shared paper, 2012 · strength 0.03
- Paper Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. DOI 10.7314/apjcp.2012.13.3.753 ↗
Shudong Chen · 1 shared paper, 2012 · strength 0.03
- Paper Knockdown of radixin by RNA interference suppresses the growth of human pancreatic cancer cells in vitro and in vivo. DOI 10.7314/apjcp.2012.13.3.753 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.